NASDAQ:GLMD

Galmed Pharmaceuticals SEC Filings & 10K Form

$3.20
+0.01 (+0.31 %)
(As of 04/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.13
Now: $3.20
$3.31
50-Day Range
$3.07
MA: $3.45
$3.93
52-Week Range
$2.96
Now: $3.20
$6.29
Volume127,702 shs
Average Volume370,200 shs
Market Capitalization$80.27 million
P/E RatioN/A
Dividend YieldN/A
Beta2.3

SEC Filings

Galmed Pharmaceuticals (NASDAQ:GLMD) SEC Filings

DateFilerForm TypeView
04/01/2021
11:15 PM
Galmed Pharmaceuticals (Filer)
Form EFFECT
03/26/2021
4:11 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2021
10:29 AM
Galmed Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/18/2021
6:29 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/16/2021
7:38 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2021
8:26 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2021
8:20 AM
Galmed Pharmaceuticals (Filer)
Form 424B5
02/16/2021
3:26 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2021
6:10 AM
Galmed Pharmaceuticals (Filer)
Form 424B5
02/16/2021
5:23 AM
Galmed Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G
02/12/2021
3:13 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
01/26/2021
10:01 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2021
10:16 AM
Galmed Pharmaceuticals (Subject)
Ibex Investors LLC (Filed by)
Form SC 13G/A
12/17/2020
6:06 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2020
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2020
7:30 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2020
9:03 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2020
3:32 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
6:13 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2020
2:22 PM
Galmed Pharmaceuticals (Subject)
Ibex Investors LLC (Filed by)
Form SC 13G
05/15/2020
3:41 PM
Galmed Pharmaceuticals (Filer)
Form 424B5
05/14/2020
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2020
6:55 AM
Galmed Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/12/2020
6:19 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2020
2:18 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2019
6:10 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2019
8:03 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2019
7:11 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2019
6:01 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2019
3:07 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2019
6:05 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2019
7:10 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2019
3:31 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2019
7:06 AM
Galmed Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2019
6:23 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2019
7:14 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
3:47 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2019
3:30 PM
Baharaff Allen (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
12/26/2018
7:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2018
3:30 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2018
3:07 PM
Galmed Pharmaceuticals (Filer)
Form S-8 POS
10/16/2018
3:30 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2018
3:02 PM
Galmed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/30/2018
3:16 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2018
6:01 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2018
4:21 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2018
4:27 PM
683 Capital Management, LLC (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G/A
06/21/2018
3:19 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2018
3:17 PM
Galmed Pharmaceuticals (Filer)
Form 424B5
06/18/2018
5:41 AM
Galmed Pharmaceuticals (Subject)
Form FWP
06/18/2018
5:37 AM
Galmed Pharmaceuticals (Filer)
Form 424B5
06/18/2018
5:35 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/09/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2018
4:27 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G
04/04/2018
3:38 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2018
3:37 PM
Galmed Pharmaceuticals (Filer)
Form 424B5
04/03/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2018
11:15 PM
Galmed Pharmaceuticals (Filer)
Form EFFECT
03/26/2018
4:07 PM
Galmed Pharmaceuticals (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
03/13/2018
6:05 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2018
6:01 AM
Galmed Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/14/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2018
6:01 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/26/2018
3:30 PM
Galmed Pharmaceuticals (Subject)
Hurvitz Chaim (Filed by)
Form SC 13G/A
01/03/2018
6:01 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/02/2018
6:00 AM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/22/2017
3:07 PM
Galmed Pharmaceuticals (Filer)
Form 424B5
12/22/2017
3:05 PM
Galmed Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2017
4:05 PM
683 Capital Management, LLC (Filed by)
Galmed Pharmaceuticals (Subject)
Form SC 13G
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.